
Antoinette R. Tan
Advertisement
Articles by Antoinette R. Tan


24 ARV-471, a PROTAC Estrogen Receptor (ER) Degrader in Advanced ER+/Human Epidermal Growth Factor Receptor 2 (HER2)– Breast Cancer: Phase 2 Expansion (VERITAC) of a Phase 1/2 Study
BySara A. Hurvitz, MD,Anne F. Schott, MD,Cynthia X. Ma, MD, PhD,Erika P. Hamilton, MD,Rita Nanda, MD,George Zahrah,Natasha Hunter, MD,Antoinette R. Tan,Melinda L. Telli, MD,Jesus Anampa Mesias,Rinath Jeselsohn,Pamela N. Munster, MD,Haolan Lu,Richard Gedrich,Cecile Mather,Janaki Parameswaran,Hyo S Han
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel 4-Biomarker Panel Improves Early Detection of Pancreatic Cancer
2
Bria-IMT Continues to Improve Survival in Metastatic Breast Cancer
3
Heavy, Consistent Alcohol Intake Increases Risk of Colorectal Cancer
4
CTD402 Receives Orphan Drug Designation For T-Cell Leukemia/Lymphoma
5

